Long-Circulating Multiple-Emulsion System for Improved Delivery of an Anticancer Agent
Open Access
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 6 (2) , 107-110
Abstract
Stealth multiple emulsions of small size, containing 6-mercaptopurine, were prepared by incorporation of sphingomyelins (SM) and monosialogangliosides (GM1) in the oily phase and by coating with lipid-grafted polyethylene glycol (PEG-PC). The three types of "stealth" multiple emulsions were characterized for size distribution, zeta potential, viscosity, encapsulation efficiency, drug release, and stability. Drug disposition studies were performed with formulated multiple emulsions to assess "stealth" behavior. The tissue distribution studies were carried out with the PEG grafted multiple emulsion. The results suggest that PEG-PC-coated multiple emulsions are superior as prolonged release and extended bloodcirculating carriers compared to multiple emulsions bearing either SM or GM1.Keywords
This publication has 5 references indexed in Scilit:
- Lectin-Functionalized Multiple Emulsions for Improved Cancer TherapyJournal of Drug Targeting, 1998
- Liposome circulation time and tumor targeting: implications for cancer chemotherapyAdvanced Drug Delivery Reviews, 1995
- Polyethylene Glycol Modified Phospholipids Stabilize Emulsions Prepared from Triacylglycerol †Journal of Pharmaceutical Sciences, 1994
- Long Circulating Emulsion Carrier Systems for Highly Lipophilic Drugs.Biological and Pharmaceutical Bulletin, 1994
- Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991